You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Primary Biliary Cholangitis (PBC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Biliary Cholangitis (PBC) Trial (Elafibranor, Matched 80 mg )

Not yet recruiting
  • Primary Biliary Cholangitis (PBC)
  • (no location specified)
Aug 29, 2023

Primary Biliary Cholangitis Trial in United States (Seladelpar 10 mg, Placebo)

Recruiting
  • Primary Biliary Cholangitis
  • Seladelpar 10 mg
  • Placebo
  • Lancaster, California
  • +4 more
Sep 26, 2023

Primary Biliary Cholangitis (PBC) Trial in Shanghai (2mg CS0159, Placebo)

Not yet recruiting
  • Primary Biliary Cholangitis (PBC)
  • 2mg CS0159
  • Placebo
  • Shanghai, Shanghai, China
    Renji Hospital, Shanghai Jiao Tong University School of Medicine
Jun 7, 2023

Primary Biliary Cholangitis Trial in United States (Seladelpar 10 mg, Placebo)

Recruiting
  • Primary Biliary Cholangitis
  • Seladelpar 10 mg
  • Placebo
  • Chandler, Arizona
  • +3 more
Oct 2, 2023

Primary Biliary Cirrhosis Trial in Edmonton (Mind-body intervention with 1-1 support from study personnel)

Completed
  • Primary Biliary Cirrhosis
  • Mind-body intervention with 1-1 support from study personnel
  • Edmonton, Alberta, Canada
    University of Alberta
Aug 2, 2022

Pruritus Trial (Linerixibat)

Available
  • Pruritus
  • (no location specified)
Jul 1, 2022

Primary Biliary Cirrhosis Trial in Edmonton (Mind-body therapy)

Active, not recruiting
  • Primary Biliary Cirrhosis
  • Mind-body therapy
  • Edmonton, Alberta, Canada
    University of Alberta
Apr 1, 2022

Primary Biliary Cholangitis (PBC), Liver Cirrhosis, Biliary Trial in Bunkyo-Ku, Fukuoka (OP-724)

Completed
  • Primary Biliary Cholangitis (PBC)
  • Liver Cirrhosis, Biliary
  • Bunkyō-Ku, Tokyo, Japan
  • +1 more
Jul 4, 2022

Chinese Primary Biliary Cholangitis on Ursodeoxycholic Acid

Recruiting
  • Primary Biliary Cholangitis (PBC)
  • Ursodeoxycholic Acid
  • Beijing, China
    Centre of non-infectious liver diseases, Beijing 302 Hospital, B
Aug 27, 2021

Evaluate Effectiveness of OCA on Hepatic Outcomes in PBC

Enrolling by invitation
  • Primary Biliary Cholangitis
  • Obeticholic Acid 5 MG
  • +2 more
  • San Diego, California
    Intercept Pharmaceuticals, Inc
Dec 15, 2022

Primary Biliary Cholangitis, Primary Biliary Cirrhosis, Cholangitis Trial in United States (HTD1801 (BUDCA))

Completed
  • Primary Biliary Cholangitis
  • +5 more
  • HTD1801 (BUDCA)
  • Miami, Florida
  • +11 more
Jun 24, 2022

Evaluate Effectiveness of OCA on Hepatic Outcomes in PBC

Completed
  • Primary Biliary Cholangitis
  • Obeticholic Acid 5 MG
  • +2 more
  • San Diego, California
    Intercept Pharmaceuticals, Inc
Jul 30, 2022

Primary Biliary Cholangitis Trial in Beijing (ursodeoxycholic acid)

Recruiting
  • Primary Biliary Cholangitis
  • ursodeoxycholic acid
  • Beijing, China
    Peking Union Medical College Hospital
Apr 28, 2022

Primary Biliary Cirrhosis Trial in Aarhus N (Thiamine, Placebo)

Recruiting
  • Primary Biliary Cirrhosis
  • Aarhus N, Region Midtjylland, Denmark
    Department of Hepatology and Gastroenterology, Aarhus University
May 19, 2021

Primary Biliary Cholangitis Trial in Canada (Emtricitabine (FTC)/Tenofovir Disoproxil (TDF), Raltegravir, Placebo Oral Capsule

Recruiting
  • Primary Biliary Cholangitis
  • Emtricitabine (FTC)/Tenofovir Disoproxil (TDF)
  • +2 more
  • Edmonton, Alberta, Canada
  • +5 more
Mar 15, 2022

Bezafibrate in Patients With Primary Biliary Cholangitis (PBC)

Recruiting
  • Primary Biliary Cirrhosis
  • Blood sampling
  • +2 more
  • Aarhus N, Region Midtjylland, Denmark
  • +1 more
Nov 3, 2020

Program for Primary Biliary Cholangitis Lost in the System

Recruiting
  • Primary Biliary Cholangitis
    • Terrassa, Barcelona, Spain
      Hospital Universitari MútuaTerrassa
    Jun 16, 2023

    Primary Biliary Cholangitis Trial in Xi'an (Fenofibrate 200mg, Placebo, UDCA)

    Recruiting
    • Primary Biliary Cholangitis
    • Fenofibrate 200mg
    • +2 more
    • Xi'an, Shaanxi, China
      Xijing Hospital
    Mar 3, 2023

    Primary Biliary Cholangitis Trial in United States (Bezafibrate 100 MG, Bezafibrate 200 MG, Obeticholic Acid 5 MG)

    Recruiting
    • Primary Biliary Cholangitis
    • Bezafibrate 100 MG
    • +4 more
    • Dothan, Alabama
    • +25 more
    Aug 24, 2022

    Primary Biliary Cholangitis Trial in Xi'an (Placebo Combined With Ursodeoxycholic Acid, Fenofibrate Combined With

    Recruiting
    • Primary Biliary Cholangitis
    • Placebo Combined With Ursodeoxycholic Acid
    • Fenofibrate Combined With Ursodeoxycholic Acid
    • Xi'an, Shaanxi, China
      Ying han
    Mar 3, 2023

    Genetic Epidemiology of Primary Biliary Cirrhosis (PBC)

    Active, not recruiting
    • Primary Biliary Cirrhosis
    • Genetic Analysis
    • Rochester, Minnesota
      Mayo Clinic
    Jan 9, 2023

    sCD163 in PBC Patients - Assessment of Treatment Response

    Recruiting
    • Primary Biliary Cirrhosis
    • +2 more
    • Blood samples
    • +3 more
    • Aarhus C, Region Midtjylland, Denmark
      Department of Hepatology and Gastroenterology, Aarhus University
    Aug 11, 2022

    Primary Biliary Cholangitis

    Recruiting
    • PBC
    • Primary Biliary Cholangitis
    • Aachen, Germany
    • +43 more
    Aug 6, 2021

    Hepatitis, Primary Biliary Cholangitis, Autoimmune Trial in Chengdu (Ursodeoxycholic acid combined with total glucosides of

    Recruiting
    • Hepatitis
    • +2 more
    • Ursodeoxycholic acid combined with total glucosides of paeony
    • Ursodeoxycholic acid only
    • Chengdu, Sichuan, China
      West China Hospital
    Mar 19, 2021

    Primary Biliary Cholangitis Trial in Beijing (Obeticholic Acid Tablets(OCA), UDCA, Placebo)

    Recruiting
    • Primary Biliary Cholangitis
    • Obeticholic Acid Tablets（OCA）
    • +2 more
    • Beijing, China
      Beijing Friendship Hospital
    Jul 7, 2022